AOP Orphan will actively call on customers in these additional markets to promote Brinavess. Cardiome chief commercial officer Karim Lalji noted making Brinavess available in significant Central/Eastern European
The European Patent Office has issued a new patent family for Livatag protecting its specific administration scheme. This first delivery should be followed by many others since the
Novartis reported sales of Fingolimod of $1,934m in 2013, representing a 62% increase from 2012. With the issuance of this patent, Mapi intends to develop a generic version
Patent #2007228341 covers the method and composition of matter for three-dimensional (3D) expansion of placental or adipose (fat) stromal cells, Pluristem’s key technology platform. Patent claims also include
Axxess president Daniel Bagi said: "This initial PO we believe is a sign of things to come, and we are very confident Mitch and his team at NPI
The study met its primary objective of protection from bleeds with fewer infusions. In the study, the site-specific PEGylated factor VIII provided protection from bleeds when used prophylactically
The randomized, double-blind study is the company’s second cancer therapy approved for clinical trials by the FDA, bolstering its platform approach to treating late stage solid-tumor cancers. The
Under the terms of the merger agreement, which has been approved by the company’s board upon the recommendation of the board’s transaction committee of independent and disinterested directors,
Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence. The
MuGard is a mucoadhesive hydrogel. The randomized, double-blind, placebo-controlled trial showed MuGard was more effective than a sham-control in significantly reducing pain associated with oral mucositis, a common
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.